View Older Stories View More Recent Stories

Nov 6, 2024 05:04PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 6, 2024 05:04PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Oct 24, 2024 07:00AM Ayana Bio to Showcase Plant Cell Advantage™ Health & Wellness Ingredients at SupplySide West 2024
Oct 4, 2024 07:38AM Form D/A Viking Global Opportunit
Oct 4, 2024 07:35AM Form D/A Viking Global Opportunit
Oct 4, 2024 07:33AM Form D/A Viking Global Equities
Oct 4, 2024 07:30AM Form D/A Viking Global Equities
Oct 4, 2024 07:03AM Form D/A Viking Global Equities
Oct 2, 2024 07:00AM Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disorders
Sep 30, 2024 04:29PM Form SC 13G BIOMARIN PHARMACEUTICAL Filed by: VIKING GLOBAL INVESTORS LP
Sep 27, 2024 02:00PM Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
Sep 27, 2024 07:45AM Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion
Sep 10, 2024 04:05PM Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
Sep 10, 2024 08:30AM Ted Seides of Capital Allocators Releases Private Equity Deals
Sep 10, 2024 08:30AM Ted Seides of Capital Allocators Releases Private Equity Deals
Sep 3, 2024 04:11PM Form N-PX VIKING GLOBAL INVESTORS For: Jun 30
Aug 22, 2024 09:00AM Synapticure and Pearl Health Partner to Provide Specialized Neurologists and Personalized Patient and Caregiver Support to Medicare Patients with Dementia
Aug 20, 2024 08:42PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2024 04:17PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Aug 13, 2024 08:00AM Pearl Health Partners With PraxisCare and Adaugeo Healthcare Solutions to Expand Value-Based Care Network in the Pacific Northwest
Aug 7, 2024 07:00AM Ayana Bio Welcomes Biotechnology Veteran Jill Zullo to its Board of Directors
Jul 30, 2024 08:00AM Pearl Health and MDX Hawaii Partner to Expand Access to Value-Based Care
Jul 23, 2024 07:00AM Magenta Medical Closes $105M Financing Led by Novo Holdings
Jul 19, 2024 10:00AM Antheia Announces New Funding to Support Domestic Production of Critical Pharmaceutical Ingredients
Jul 15, 2024 04:18PM Form SC 13G Longboard Pharmaceutical Filed by: VIKING GLOBAL INVESTORS LP
Jul 8, 2024 11:04AM AlphaSense Completes Acquisition Of Tegus
Jun 26, 2024 04:05PM Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
Jun 20, 2024 01:50PM Pearl Health CEO Michael Kopko recognized as an EY Entrepreneur Of The Year® 2024 New York Award Winner
Jun 18, 2024 05:06PM Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Jun 18, 2024 04:05PM Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
Jun 18, 2024 10:00AM Mexican Fintech Unicorn Clip Announces US$100 Million Investment
Jun 11, 2024 04:05PM Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Jun 11, 2024 09:32AM AlphaSense valued at $4 billion in latest funding, agrees $930 million deal for rival Tegus
Jun 11, 2024 09:01AM AlphaSense to Join Forces with Tegus; Increases Latest Valuation to $4B
Jun 7, 2024 04:24PM Form SC 13G Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
Jun 3, 2024 05:56PM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jun 3, 2024 02:30PM Mythic Therapeutics Presents Initial Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024 08:00AM Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
May 25, 2024 06:51AM HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients
May 24, 2024 07:02AM HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
May 23, 2024 08:17AM Mythic Therapeutics to Present Data from Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 22, 2024 09:00AM Pearl Health releases Top 50 Value-Based Care Thinkers of 2024
May 22, 2024 07:31AM Biogen (BIIB) to Acquire Human Immunology Biosciences for $1.15B Upfront Plus Milestone Payments
May 22, 2024 07:30AM Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
May 15, 2024 07:26PM Hedge fund Coatue scraps its Apple stake in Q1, while Viking built its position
May 15, 2024 04:06PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
May 9, 2024 12:00PM With Vim as a Strategic Technology Partner, Pearl Health Launches Enhanced EHR Experience
May 8, 2024 09:49AM AbCellera Biologics (ABCL) PT Lowered to $7 at KeyBanc
May 7, 2024 04:05PM AbCellera Reports Q1 2024 Business Results
May 1, 2024 09:00AM AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
View More Recent Stories View Older Stories